Fat has a bad reputation, both in food and on the body. It’s certainly true that the U.S. has a problem with body fat; according to the U.S. Centers for Disease Control and Prevention (CDC), about two-thirds of adults in the U.S. are overweight, and fully one-third of adults fall into the more serious “obese” category . Still, appropriate amounts of body fat serve valuable roles. These include helping to maintain the immune system and nervous system, protecting body organs and padding areas where the skeleton would otherwise put pressure directly on the skin (such as the soles of the feet).
The National Institutes of Health today announced an agreement with two non-profit organizations to accelerate the development of potential clinical therapies for rare blood cancers.
The cooperative research and development agreement has been established as a shared commitment to move therapies for rare blood cancers into clinical proof-of-concept studies so that promising treatments can eventually be commercialized. The agreement is among the University of Kansas Medical Center, The Leukemia & Lymphoma Society (LLS), the NIH Therapeutics for Rare and Neglected Diseases (TRND) program and the Hematology Branch within the National Heart, Lung and Blood Institute (NHLBI).